Role of infarct size in explaining the higher mortality in older patients with acute myocardial infarction

American Journal of Cardiology

Volumn 90, Issue 12, 2002, Pages 1370-1374

  Miller, Todd D ^a,b   Piegas, Leopoldo S ^a,b   Gibbons, Raymond J ^a,b   Yi, Cheelong ^a,b   Yusuf, Salim ^a,b  

^a MAYO CLINIC   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE NECROSIS; HEART SCINTISCANNING; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; AGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; STROKE VOLUME; SURVIVAL ANALYSIS; TECHNETIUM TC 99M SESTAMIBI; VENTRICULAR FUNCTION, LEFT;

EID: 0037114793     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02875-8     Document Type: Article

References (20)

1. Tofler G.H., Muller J.E., Stone P.H., Willich S.N., Davis V.G., Poole W.K., Braunwald E. Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients. Am J Cardiol. 62:1988;860-867.
2. Marcus F.I., Friday K., McCans J., Moon T., Hahn E., Cobb L., Edwards J., Kuller L. Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction Trial). Am J Cardiol. 65:1990;559-566.
3. Smith S.C. Jr, Gilpin E., Ahnve S., Dittrich H., Nicod P., Henning H., Ross J. Jr. Outlook after acute myocardial infarction in the very elderly compared with thatin patients aged 65 to 75 years. (see comments) J Am Coll Cardiol. 16:1990;784-792.
4. Rich M.W., Bosner M.S., Chung M.K., Shen J., McKenzie J.P. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? (see comments) Am J Med. 92:1992;7-13.
5. Udvarhelyi I.S., Gatsonis C., Epstein A.M., Pashos C.L., Newhouse J.P., McNeil B.J. Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA. 268:1992;2530-2536.
6. Maggioni A.P., Maseri A., Fresco C., Franzosi M.G., Mauri F., Santoro E., Tognoni G. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med. 329:1993;1442-1448.
7. Aguirre F.V., McMahon R.P., Mueller H., Kleiman N.S., Kern M.J., Desvigne-Nickens P., Hamilton W.P., Chaitman B.R. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators. Circulation. 90:1994;78-86.
8. Calle P., Jordaens L., De Buyzere M., Rubbens L., Lambrecht B., Clement D.L. Age-related differences in presentation, treatment and outcome of acute myocardial infarction. Cardiology. 85:1994;111-120.
9. Devlin W., Cragg D., Jacks M., Friedman H., O'Neill W., Grines C. Comparison of outcome in patients with acute myocardial infarction aged >75 years with that in younger patients. Am J Cardiol. 75:1995;573-576.
10. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., Van de Werf F., Califf R.M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. (see comments) Circulation. 91:1995;1659-1668.
11. McLaughlin T.J., Soumerai S.B., Willison D.J., Gurwitz J.H., Borbas C., Guadagnoli E., McLaughlin B., Morris N., Cheng S.C., Hauptman P.J., et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction evidence for undertreatment in women and the elderly . Arch Intern Med. 156:1996;799-805.
12. Soumerai S.B., McLaughlin T.J., Spiegelman D., Hertzmark E., Thibault G., Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. (see comments) JAMA. 277:1997;115-121.
13. Gibbons R.J., Miller T.D., Christian T.F. Infarct size measured by single photon emission computed tomographic imaging with 99mTc-sestamibi - a measure of the efficacy of therapy in acute myocardial infarction. Circulation. 101:2000;101-108.
14. Miller T.D., Christian T.F., Hodge D.O., Hopfenspirger M.R., Gersh B.J., Gibbons R.J. Comparison of acute myocardial infarct size to two-year mortality in patients <65 to those ≥65 years of age. Am J Cardiol. 84:1999;1170-1175.
15. Anonymous. Effects of RheothRx on mortality, morbidity, left ventricular function, and infarct size in patients with acute myocardial infarction. Collaborative Organization for RheothRx Evaluation (CORE). Circulation. 96:1997;192-201.
16. Chareonthaitawee P., Gibbons R.J., Roberts R.S., Christian T.F., Burns R., Yusuf S. The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation). Heart. 84:2000;142-148.
17. Gibbons R.J., Holmes D.R., Reeder G.S., Bailey K.R., Hopfenspirger M.R., Gersh B.J. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. (see comments) N Engl J Med. 328:1993;685-691.
18. Burns R.J., Druck M.N., Woodward D.S., Houle S., McLaughlin P.R. Repeatability of estimates of left-ventricular volume from blood-pool counts concise communication . J Nucl Med. 24:1983;775-781.
19. O'Connor M.K., Gibbons R.J., Juni J.E., O'Keefe J. Jr, Ali A. Quantitative myocardial SPECT for infarct sizing feasibility of a multicenter trial evaluated using a cardiac phantom . J Nucl Med. 36:1995;1130-1136.
20. Kloner R.A., Poole K., Shook T., Przyklenk K., Perritt K., Cannon C.P. Comparison of acute myocardial infarct size in patients ≥65 years versus <65 years in the prethrombolytic period versus the thrombolytic period. Am J Cardiol. 89:2002;1291-1293.